Search results for: 'Vitro Diagnostics Market'

The study provides a U.S. market scenario for molecular diagnostics markets. The markets are divided as Infectious diseases, cancer, and pharmacogenomics markets. Emerging markets in molecular diagnostics are also discussed. Product analysis and technology analysis are detailed in the study. The study provides competitive position of key market par...

The U.S. Osteoporosis Diagnostics Market report focuses on the varying dynamics of the bone densitometry market. This report covers Osteoporosis Diagnostics equipment for axial and peripheral measurement sites, over a ten-year period. Osteoporosis technologies relating to this report include DXA, QCT, Quantitative Ultrasound and Radiographic Abso...

This research service provides market intelligence, analysis, and forecasts for the U.S. immunoassay diagnostics market. A detailed analysis is provided with regard to these immunoassay diagnostic tests, immunoassay analyzers, companies that manufacture and distribute them, and end-users that purchase them. The forecast period is 2007 through 2013 ...

30 Oct 2024  |  Global  |  Market Research

Clinical Chemistry and Immunoassay Industry, Global, 2023?2028

Integrated and Scalable Core Lab Solutions Driving Transformational Growth

Infographics

×

This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to s...

19 Sep 2023  |  North America  |  Market Research

Growth Opportunities for Clinical Laboratory Services in Asia-Pacific

Proliferation of High-end Specialized Testing and Interconnected Lab Networks Fuel Growth Potential

Infographics

×

Clinical labs are the foundation of the healthcare ecosystem. This research overviews the Asia-Pacific (APAC) clinical laboratory services industry for the period 2022–2028. Country-specific and vertical-specific forecasts are provided from 2023 to 2028 using a base year of 2022. Frost & Sullivan focused on APAC following various events unfolding f...

23 Jun 2016  |  North America  |  Market Research

Growth Opportunities in the US Point-of-care Testing Market

Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics

Infographics

×

The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...

The diabetes diagnostics market in South Korea is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The analysis time frame for this study was from 2002 to 2012, with 2005 being the base year of the study. The forecast period is 2006 to 2012 and historic period is 2002 to 2004.

This research service evaluates the global autoimmune disease diagnostics markets from 2009 to 2018. The market includes two segments, which include analysis for the markets for localized autoimmune disease diagnostic tests and for the systemic autoimmune disease diagnostic tests. This research service offers a discussion of the key market drivers ...

This study addresses the imaging services trends and challenges seen at various global outpatient imaging sites. The focus of this study addresses various imaging services provided using modalities such as fixed and portable X-ray and ultrasound devices as well as advanced imaging equipment such as mammography, CT, MRI, C-arm, and molecular imaging...